PMC:7127386 / 14925-15262
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 504 | 43-51 | Species | denotes | patients | Tax:9606 |
| 505 | 311-321 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 511 | 76-87 | Chemical | denotes | omacetaxine | MESH:D000077863 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T48 | 147-153 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T108 | 311-319 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T106 | 147-153 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T107 | 233-235 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
| T108 | 322-327 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T100 | 0-337 | Sentence | denotes | Previous pharmacokinetic study showed that patients treated with 1.25 mg/m2 omacetaxine every 12 h by subcutaneous injection may reach the maximal plasma concentration at 25.1 ng/mL (0.046 μM) and 36.2 ng/mL (0.066 μM) on days 1 and 11, respectively (Nemunaitis et al., 2013), which were below the EC50 against SARS-CoV-2 virus in vitro. |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T372 | 76-87 | CHEBI:25675;CHEBI:25675 | denotes | omacetaxine |
| T373 | 147-153 | UBERON:0001969 | denotes | plasma |
| T374 | 311-321 | SP_7 | denotes | SARS-CoV-2 |
| T375 | 322-327 | NCBITaxon:10239 | denotes | virus |
| T1785 | 2-13 | NCBITaxon:6073 | denotes | evious phar |
| T71027 | 15-21 | NCBITaxon:9654 | denotes | cokine |
| T80641 | 22-27 | NCBITaxon:10376 | denotes | ic st |
| T1065 | 36-45 | NCBITaxon:33758 | denotes | d that pa |
| T80588 | 49-56 | NCBITaxon:9940 | denotes | ts trea |
| T69278 | 57-65 | NCBITaxon:9258 | denotes | ed with |
| T72172 | 67-73 | NCBITaxon:27592 | denotes | 25 mg/ |
| T2968 | 74-88 | NCBITaxon:5690 | denotes | 2 omacetaxine |
| T54511 | 92-97 | NCBITaxon:9258 | denotes | y 12 |
| T78740 | 102-108 | NCBITaxon:7656 | denotes | subcut |
| T6403 | 109-118 | NCBITaxon:7729 | denotes | neous inj |
| T46358 | 119-124 | NCBITaxon:10239 | denotes | ction |
| T13633 | 126-135 | NCBITaxon:6231 | denotes | ay reach |
| T23133 | 136-150 | NCBITaxon:10376 | denotes | he maximal pla |
| T36362 | 152-158 | NCBITaxon:5690 | denotes | a conc |
| T95862 | 159-166 | NCBITaxon:10633 | denotes | ntratio |
| T61572 | 167-172 | NCBITaxon:10376 | denotes | at 2 |
| T32709 | 176-189 | NCBITaxon:7737 | denotes | ng/mL (0.046 |
| T13406 | 191-208 | NCBITaxon:11588 | denotes | ) and 36.2 ng/mL |
| T29449 | 209-214 | NCBITaxon:10239 | denotes | 0.066 |